Brief: Enanta Pharmaceuticals Q4 Revenue USD 14.607 Million Vs. IBES Estimate USD 17.9 Million
25/11/2024 21:01
Nov 25 (Reuters) - Enanta Pharmaceuticals Q4 operating expenses USD 44.461 million. * Q4 pretax profit USD -29.186 million * Q4 net income USD -28.823 million vs. IBES estimate USD -25.7 million * Q4 operating income USD -29.854 million
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates